JPMorgan Chase & Co’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $638 | Sell |
281
-105,013
| -100% | -$238K | ﹤0.01% | 5782 |
|
2025
Q1 | $66.9K | Sell |
105,294
-706,336
| -87% | -$449K | ﹤0.01% | 4922 |
|
2024
Q4 | $836K | Buy |
811,630
+811,349
| +288,736% | +$836K | ﹤0.01% | 3899 |
|
2024
Q3 | $332 | Hold |
281
| – | – | ﹤0.01% | 5773 |
|
2024
Q2 | $343 | Hold |
281
| – | – | ﹤0.01% | 5703 |
|
2024
Q1 | $613 | Hold |
281
| – | – | ﹤0.01% | 5675 |
|
2023
Q4 | $436 | Sell |
281
-1,449
| -84% | -$2.25K | ﹤0.01% | 5905 |
|
2023
Q3 | $2.23K | Hold |
1,730
| – | – | ﹤0.01% | 5573 |
|
2023
Q2 | $2.98K | Hold |
1,730
| – | – | ﹤0.01% | 5376 |
|
2023
Q1 | $3K | Hold |
1,730
| – | – | ﹤0.01% | 5474 |
|
2022
Q4 | $3K | Sell |
1,730
-2,672
| -61% | -$4.63K | ﹤0.01% | 5295 |
|
2022
Q3 | $6K | Buy |
4,402
+1,425
| +48% | +$1.94K | ﹤0.01% | 5152 |
|
2022
Q2 | $5K | Sell |
2,977
-302,055
| -99% | -$507K | ﹤0.01% | 5294 |
|
2022
Q1 | $814K | Sell |
305,032
-2,197
| -0.7% | -$5.86K | ﹤0.01% | 3741 |
|
2021
Q4 | $1.33M | Sell |
307,229
-13,037
| -4% | -$56.4K | ﹤0.01% | 3497 |
|
2021
Q3 | $1.63M | Sell |
320,266
-21,269
| -6% | -$108K | ﹤0.01% | 3301 |
|
2021
Q2 | $2.16M | Buy |
341,535
+269,329
| +373% | +$1.71M | ﹤0.01% | 3178 |
|
2021
Q1 | $559K | Sell |
72,206
-8,318
| -10% | -$64.4K | ﹤0.01% | 3986 |
|
2020
Q4 | $528K | Sell |
80,524
-11,781
| -13% | -$77.2K | ﹤0.01% | 3714 |
|
2020
Q3 | $618K | Sell |
92,305
-7,275
| -7% | -$48.7K | ﹤0.01% | 3297 |
|
2020
Q2 | $828K | Sell |
99,580
-76,433
| -43% | -$636K | ﹤0.01% | 3100 |
|
2020
Q1 | $1.35M | Sell |
176,013
-192,992
| -52% | -$1.48M | ﹤0.01% | 2806 |
|
2019
Q4 | $3.07M | Buy |
369,005
+234,743
| +175% | +$1.95M | ﹤0.01% | 2462 |
|
2019
Q3 | $991K | Buy |
134,262
+6,969
| +5% | +$51.4K | ﹤0.01% | 3072 |
|
2019
Q2 | $1.35M | Sell |
127,293
-7,166
| -5% | -$76.1K | ﹤0.01% | 2901 |
|
2019
Q1 | $1.45M | Sell |
134,459
-8,611
| -6% | -$92.6K | ﹤0.01% | 2833 |
|
2018
Q4 | $2.16M | Sell |
143,070
-7,514
| -5% | -$113K | ﹤0.01% | 2606 |
|
2018
Q3 | $2.79M | Buy |
150,584
+10,653
| +8% | +$197K | ﹤0.01% | 2603 |
|
2018
Q2 | $3.2M | Sell |
139,931
-61,130
| -30% | -$1.4M | ﹤0.01% | 2523 |
|
2018
Q1 | $5.72M | Sell |
201,061
-42,478
| -17% | -$1.21M | ﹤0.01% | 2123 |
|
2017
Q4 | $5.14M | Buy |
243,539
+4,989
| +2% | +$105K | ﹤0.01% | 2230 |
|
2017
Q3 | $4.31M | Sell |
238,550
-4,200
| -2% | -$75.9K | ﹤0.01% | 2245 |
|
2017
Q2 | $3.76M | Buy |
242,750
+56,972
| +31% | +$883K | ﹤0.01% | 2288 |
|
2017
Q1 | $3.21M | Buy |
185,778
+157,261
| +551% | +$2.72M | ﹤0.01% | 2349 |
|
2016
Q4 | $313K | Buy |
+28,517
| New | +$313K | ﹤0.01% | 3474 |
|